Syringe cracks prompt J&J Janssen recall

A production line for J&J unit Janssen's antipsychotic drug Invega Sustenna is back in operation following an investigation into cracked syringes. A 70,000-dose recall is under way.

Users are unlikely to have seen the cracks on the syringe barrel because they were covered by labels. The defect was found during routine testing at the Belgium manufacturing site. Janssen suspects that stress during label application caused the cracking.

Only 234-mg dose syringes have shown the cracking. Distribution began last March, and the recall notice was sent to distributors, pharmacists and healthcare providers in the U.S., Australia, Canada and South Korea.

- see the story
- here's the recall notice


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.